Trial Profile
Characterization of the Analgesic Effects of Oral CBD in Healthy, Normal Volunteers
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 13 May 2021
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Pain
- Focus Therapeutic Use
- 19 Apr 2021 Status changed from active, no longer recruiting to completed.
- 01 Apr 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2021.
- 01 Apr 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2021.